Alaunos Therapeutics Inc TCRT

US Biotechnology

$1.09 ▼ -3.54% ($-0.04)

⬇️ Below Yest. Low

Open $1.13

Prev Close $1.13

Day Range $1.08 – $1.13

52W Range $1.02 – $4.59

Market Cap $2.77M

Beta -0.91

EPS (TTM) $-1.82

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2004-08-20
Shares Out.	2,440,000
Website	alaunos.com/ ↗
Phone	13463554099
Employees	1
Revenue	$0
Gross Profit	$0
Net Income	-$952,000
Free Cash Flow	-$2.8M
Total Assets	$1.5M
Total Liabilities	$864,000
Equity	$652,000

About Alaunos Therapeutics Inc

Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.

Alaunos Therapeutics Inc is a publicly traded company under the ticker symbol TCRT on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.